Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants-Reference-Cited by-同舟云学术

Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants

Published:2021-12 Issue: Volume:101 Page:108216
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

He Lei,Sun Bo,Guo Yingnan,Yan Kunming,Liu Dawei,Zang Yang,Jiang Chunlai,Zhang Yong,Kong Wei

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference48 articles.

1. Epidemiology, outcome and control of varicella-zoster infection.;Miller;Revi. Med. Microbiol.,1993

2. Pathogenesis and current approaches to control of varicella-zoster virus infections;Gershon;Clin. Microbiol. Rev.,2013

3. Committee on Immunization Practices Centers for Disease, Prevention, Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP);Harpaz;MMWR Recomm. Rep.,2008

4. Risk of Stroke/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis;Zhang;J. Stroke Cerebrovasc. Dis,2017

5. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity;Otani;J. Immunol. Methods,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice;International Journal of Nanomedicine;2024-08

2. Development of semisynthetic saponin immunostimulants;Medicinal Chemistry Research;2024-05-18

3. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2;Vaccine;2023-09

4. Corrigendum to “Immune response of C57BL/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants” [Int. Immunopharmacol. 101(Part B) (2021) 108216];International Immunopharmacology;2023-06

5. LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix™ in VZV-primed mice;Virologica Sinica;2022-10